Asperger syndrome (AS) is a developmental disorder. It is an autism spectrum disorder (ASD), one of a distinct group of neurological conditions characterized by a greater or lesser degree of impairment in language and communication skills, as well as repetitive or restrictive patterns of thought and behavior. Other ASDs include: classic autism, Rett syndrome, childhood disintegrative disorder, and pervasive developmental disorder not otherwise specified (usually referred to as PDD-NOS). Unlike children with autism, children with AS retain their early language skills.
The most distinguishing symptom of AS is a child’s obsessive interest in a single object or topic to the exclusion of any other. Children with AS want to know everything about their topic of interest and their conversations with others will be about little else. Their expertise, high level of vocabulary, and formal speech patterns make them seem like little professors. Other characteristics of AS include repetitive routines or rituals; peculiarities in speech and language; socially and emotionally inappropriate behavior and the inability to interact successfully with peers; problems with non-verbal communication; and clumsy and uncoordinated motor movements.
Children with AS are isolated because of their poor social skills and narrow interests. They may approach other people, but make normal conversation impossible by inappropriate or eccentric behavior, or by wanting only to talk about their singular interest. Children with AS usually have a history of developmental delays in motor skills such as pedaling a bike, catching a ball, or climbing outdoor play equipment. They are often awkward and poorly coordinated with a walk that can appear either stilted or bouncy.
The ideal treatment for AS coordinates therapies that address the three core symptoms of the disorder: poor communication
skills, obsessive or repetitive routines, and physical clumsiness. There is no single best treatment package for all children
with AS, but most professionals agree that the earlier the intervention, the better.
An effective treatment program builds on the child’s interests, offers a predictable schedule, teaches tasks as a series of
simple steps, actively engages the child’s attention in highly structured activities, and provides regular reinforcement of
behavior. It may include social skills training, cognitive behavioral therapy, medication for co-existing conditions, and
other measures.
With effective treatment, children with AS can learn to cope with their disabilities, but they may still find social situations
and personal relationships challenging. Many adults with AS are able to work successfully in mainstream jobs, although they
may continue to need encouragement and moral support to maintain an independent life.
Many of the Institutes at the NIH, including the NINDS, are sponsoring research to understand what causes AS and how it can
be effectively treated. One study is using functional magnetic resonance imaging (fMRI) to show how abnormalities in particular
areas of the brain cause changes in brain function that result in the symptoms of AS and other ASDs. Other studies include
a clinical trial testing the effectiveness of an anti-depressant in individuals with AS and HFA who exhibit high levels of
obsessive/ritualistic behavior and a long-range study to collect and analyze DNA samples from a large group of children with
AS and HFA and their families to identify genes and genetic interactions that are linked to AS and HFA.
MAAP Services for Autism, Asperger Syndrome, and PDD P.O. Box 524 Crown Point, IN 46308 info@maapservices.org http://www.maapservices.org Tel: 219-662-1311 Fax: 219-662-0638 |
Autism Network International (ANI) P.O. Box 35448 Syracuse, NY 13235-5448 jisincla@syr.edu www.ani.ac |
Autism Society of America 7910 Woodmont Ave. Suite 300 Bethesda, MD 20814-3067 http://www.autism-society.org Tel: 301-657-0881 800-3AUTISM (328-8476) Fax: 301-657-0869 |
Autism Research Institute (ARI) 4182 Adams Avenue San Diego, CA 92116 director@autism.com http://www.autismresearchinstitute.com Tel: 619-281-7165 Fax: 619-563-6840 |
National Institute of Mental Health (NIMH) National Institutes of Health, DHHS 6001 Executive Blvd. Rm. 8184, MSC 9663 Bethesda, MD 20892-9663 nimhinfo@nih.gov http://www.nimh.nih.gov Tel: 301-443-4513/866-415-8051 301-443-8431 (TTY) Fax: 301-443-4279 |
National Institute on Deafness and Other
Communication Disorders Information Clearinghouse 1 Communication Avenue Bethesda, MD 20892-3456 nidcdinfo@nidcd.nih.gov http://www.nidcd.nih.gov Tel: 800-241-1044 800-241-1055 (TTD/TTY) |
Prepared by:
Office of Communications and Public Liaison
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD 20892
NINDS health-related material is provided for information purposes only and does not necessarily represent endorsement by or an official position of the National Institute of Neurological Disorders and Stroke or any other Federal agency. Advice on the treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient's medical history.
All NINDS-prepared information is in the public domain and may be freely copied. Credit to the NINDS or the NIH is appreciated.
Last updated April 24, 2009